C.M. Bidwell & Associates’s Patterson-UTI PTEN Stock Holding History

C.M. Bidwell & Associates’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,872	Closed	-$106K	–	580
2023 Q2	$106K	Buy	8,872 +680	+8%	+$7.67K	0.08%	231
2023 Q1	$95.8K	Sell	8,192 -1,140	-12%	-$16.6K	0.07%	239
2022 Q4	$157K	Hold	9,332	–	–	0.12%	148
2022 Q3	$109K	Sell	9,332 -3,213	-26%	-$45.9K	0.09%	203
2022 Q2	$198K	Sell	12,545 -1,410	-10%	-$23.7K	0.16%	115
2022 Q1	$216K	Buy	+13,955	New	+$176K	0.14%	144
2017 Q4	–	Sell	-6,015	Closed	-$126K	–	436
2017 Q3	$126K	Sell	6,015 -86,000	-93%	-$1.58M	0.19%	151
2017 Q2	$1.86M	Hold	92,015	–	–	0.4%	84
2017 Q1	$2.23M	Buy	+92,015	New	+$2.48M	0.5%	80
2014 Q4	–	Sell	-9,810	Closed	-$319K	–	243
2014 Q3	$319K	Buy	+9,810	New	+$333K	0.08%	115

Other funds holding PTEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCM

Cerberus Capital Management New York $2.1B AUM 36.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

C.M. Bidwell & Associates's PTEN Position: Q3 2023 in Review

C.M. Bidwell & Associates sold out of Patterson-UTI (PTEN) in Q3 2023, closing a stake of 8,872 shares — an estimated $106K sold.

C.M. Bidwell & Associates first reported a position in PTEN in Q3 2014 and held it in 10 quarters. The position peaked at $2.23M in Q1 2017. 357 funds tracked by Wall St. Rank hold PTEN as of Q3 2023.

C.M. Bidwell & Associates reported no remaining Patterson-UTI position as of Q3 2023 after selling out during the quarter.
C.M. Bidwell & Associates sold 8,872 Patterson-UTI shares in Q3 2023, an estimated $106K.
C.M. Bidwell & Associates first reported a position in Patterson-UTI in Q3 2014 and held it in 10 quarters.
C.M. Bidwell & Associates's Patterson-UTI position peaked at $2.23M in Q1 2017.
357 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.